✨ Your Portfolio is fetched and updated from zerodha.
Small Miscellaneous

Novartis India Ltd.

NOVARTIND

Market Cap
₹2,513 Cr.
P/E
24.90

Novartis India Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
2,513 Cr
PE
PE
24.90
Prom Holding
Prom Holding
70.68 %
ROE (%)
ROE (%)
11.44
ROCE (%)
ROCE (%)
8.51
Div Yield (%)
Div Yield (%)
4.91
Sales
Sales
356 Cr
OPM (%)
OPM (%)
25.66 %
Debt to Equity
Debt to Equity
-
View more
Edit Ratio's
About
Novartis India Limited is a pharmaceutical company with operations in Pharmaceuticals, Generic… Read more
Low
745
52W Range
High
1248
  • Novartis
  • Panacea Biotec
  • Indoco Remedies
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
1.80 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
0.06 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
0.09 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
0.14 %
(as of May 19)
Historic
Blood Related - Market Share
0.72 %
(as of Jul 22)
Historic
Cardiovascular - Market Share
0.03 %
(as of Nov 21)
Historic
Dermatology - Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    Peer Comparison
    Brands
    Voveran
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Suppliers
    • Bharat Dynamics Ltd.
    • Piramal Enterprises Ltd.
    • Navin Fluorine International Ltd.
    • Aarti Industries Ltd.
    • Neuland Laboratories Ltd.
    FAQs on Novartis India Ltd. Business

    Novartis India Limited operates in pharmaceuticals, generics, over the counter (OTC), and animal health segments. It provides prescription medicines, retail generic products, and products for cattle and poultry markets.

    Novartis major competitors are Panacea Biotec, Indoco Remedies, Zota Health Care, Syncom Formulations, Beta Drugs, Guj. Themis Biosyn, Orchid Pharma.
    Market Cap of Novartis is ₹2,513 Crs.
    While the median market cap of its peers are ₹2,612 Crs.

    Novartis seems to be less financially stable compared to its competitors.
    Altman Z score of Novartis is 2.43 and is ranked 8 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation Dec
    Conference Call
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material